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INTRODUCTION
The global incidence of cancer has
increased by approximately 20% in the
past decade, an increase mostly due to
cases in low- and middle-income coun-
tries (LMICs) (1). By 2020, up to 70% of
the 20 million annual new cancer cases
are expected to occur in LMICs (2). The
incidence of cancer in LMICs is increasing
rapidly; however, many countries are not
prepared to address this epidemic. Can-
cer survival rates in LMICs are often less
than one-third of those in high-income
countries (3). In addition to local capacity-
building efforts, the involvement of the
oncology community from high-income
countries will be instrumental in chang-
ing the course of this impending global
cancer crisis.
There is a vital need to train global
oncologists to work with colleagues in
LMICs to develop sustainable capacity
and infrastructure for clinical oncology
care, research, and education. However,
enumeration of specific goals and novel
programs, and the path to implement-
ing these programs, is not clear. Oncology
programs in North America lack for-
mal training or exposure to global oncol-
ogy. Even without a formal curriculum,
with the rise in global health (GH)
oncology interest, several opportunities
have developed for trainees committed to
GH. We describe herein current opportu-
nities and future directions for oncology
trainees in the United States (US) who
are interested in pursuing careers as global
oncologists.
CURRENT OPPORTUNITIES
MEDICAL AND PEDIATRIC ONCOLOGY
Many US training programs have
responded to the growing interest in GH by
offering international training opportuni-
ties. A survey of 380 US internal medicine
residency programs showed that 57% of
responding programs offered opportuni-
ties for international rotations (4). When
selecting a residency program,22% of pedi-
atric residents indicated that GH training
opportunities were essential/very impor-
tant and 21% had a GH experience during
pediatric residency (5). There has also been
an increase in GH fellowships. A recent sur-
vey identified 80 GH fellowship programs,
14% of which were in internal medicine
(6). For medical and pediatric oncology
fellowships, there is scant information
regarding trainee interest and the availabil-
ity of international rotations. Few insti-
tutions have GH partnerships that offer
opportunities for training, research, and
career development in medical and pedi-
atric oncology. The available opportunities
are highlighted below.
1. The American Society of Clinical
Oncology (ASCO) supports the Health
Volunteers Overseas (HVO) program
that recruits oncologists, faculty, and
senior internal medicine residents to
strengthen cancer care in LMICs. The
program creates a forum for oncolo-
gists to share their medical expertise
and build sustainable relationships with
physicians addressing cancer care in
these regions (7, 8).
2. Medicine residents pursue individu-
ally tailored curriculums in the form
of short-term elective rotations at
cancer centers in LMICs partnered
with a US based institution, such as
Botswana – University of Pennsylva-
nia (9) and Yale/Stanford Johnson &
Johnson Global Health Scholars Pro-
grams (10).
3. International pediatric oncology twin-
ning programs through institutions like
St. Jude Children’s Research Hospital,
Children’s Hospital Boston/Dana-
Farber Cancer Institute, and Texas
Children’s Hospital/Baylor College
of Medicine offer GH opportunities
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during pediatric hematology–oncology
fellowship (11–13).
4. Graduates of internal medicine and
pediatrics residencies can apply for a 1-
to 2-year research and leadership role in
clinical cancer care at the Butaro Can-
cer Center of Excellence (BCCOE) in
Rwanda. They are mentored by local
clinical leaders from Partners in Health,
the Rwandan Ministry of Health and
oncologists from the Dana-Farber Can-
cer Institute. More recently, funding has
become available for a recent graduate
of an oncology fellowship program to
spend a year at the University Hospital
at Mirebalais in Haiti (14).
5. The Academic Model for Providing
Access to Healthcare (AMPATH) con-
sortium, involving many North Amer-
ican centers led by Indiana University
School of Medicine, offers oncology
experience in Kenya through a part-
nership with Moi University School of
Medicine and Moi Teaching and Refer-
ral Hospital (15).
Finally, for trainees and faculty mem-
bers interested in global oncology in Africa,
the African Organization for Research
and Training in Cancer (AORTIC) con-
ference brings together oncology profes-
sionals from Africa and abroad to present
scientific work and participate in cancer
education in Africa (16).
The existing requirements for medical
and pediatric oncology fellowships in US
by the Accreditation Council for Grad-
uate Medical Education (ACGME) make
active participation in global cancer activ-
ities during the core 3-year fellowship a
challenge. Currently, significant barriers
include the need for longitudinal patient
care and on-site mentorship by board cer-
tified oncologists. For a fellow to spend
significant time at a global site, it would
likely need to be done after the core fel-
lowship as an “unofficial” advanced fellow-
ship, additional time that might thwart GH
interest. Ideally, ACGME and individual
programs will work together to incorpo-
rate time for optional GH activities into
the core fellowship.
SURGICAL ONCOLOGY
Benefits of international rotations in
LMICs for surgical residents include
exposure to pathology distinct from that
seen at the home institution, alternative
disease management, cultural influences
on disease presentation, and relationship
building (17). For surgical oncology fel-
lows specifically, the learning benefits of
rotations in LMICs are even greater as can-
cer patients have fewer screening options,
often present at advanced stages, might
have different cancer biology, fewer imag-
ing options, as well as limited perioperative
care (18–20).
There are few residencies in general
surgery and gynecology with an established
global rotation. One such opportunity is
the Paul Farmer Global Surgery fellowship,
which is typically a 1- to 2-year fellowship
following surgical residency, which gives
recent graduates experience in GH research
and surgical oncology in resource-poor
settings, such as Haiti and Rwanda (21).
Of the 243 accredited U.S. obstetrics
and gynecology residency programs, 34%
offer formal didactics and 28% offer a for-
mal rotation in global women’s health (22).
Residents who participate in an interna-
tional rotation are often very motivated to
continue their involvement. However, once
they start fellowship training opportuni-
ties to spend time abroad are limited. Of
the 22 surgical oncology and 46 gyneco-
logic oncology fellowship programs, only
1 program offers an international experi-
ence on their website. The Society of Gyne-
cologic Oncology (SGO) welcomes inter-
national research and offers membership
at reduced fees to international members
from LMICs; a support program is also
available for international attendees of the
annual conference. However, no grants are
available to our knowledge for fellows who
are planning overseas research or work.
RADIATION ONCOLOGY
While there is an increasing level of interest
in GH oncology outreach among radiation
oncology residents, available opportunities
are very limited. A Global Health Interest
Survey administered by the Association of
Residents in Radiation Oncology (ARRO)
in 2009 revealed that of 115 residents com-
pleting the survey, approximately 90% of
respondents were interested in an interna-
tional radiation oncology experience dur-
ing their residency and 80% wished to
incorporate international work in their
future careers. However, <10% of the
respondents had GH educational activities
within their residency. Moreover, many res-
idents noted barriers to an international
rotation (funding, elective time, program
director support) as well as unavailabil-
ity of faculty guidance/mentorship at their
home institution to foster GH interest (23).
The American Society of Radiation
Oncology (ASTRO), in conjunction with
ARRO and the American College of Radi-
ology (ACR), promote international out-
reach by sponsoring travel grants. Annu-
ally, the ACR Foundation Goldberg-Reeder
Resident Travel Grant awards $1500 to res-
idents in order to spend at least 1 month
assisting health care in a LMIC.
The ASTRO-ARRO Global Health
Scholars Program also provides $2500
scholarships to selected residents for self-
designed research, clinical or educational
projects. Similarly, the Canadian Associa-
tion of Radiation Oncology (CARO) has
recently launched a GH scholarship for res-
idents and fellows, which provides 2500
CAD for a clinical or research elective in
a LMIC.
A few residency programs have incorpo-
rated international outreach into their cur-
riculum. Through the Botswana-UPenn
Partnership (24), residents at the University
of Pennsylvania and elsewhere can pro-
vide clinical care in a LMIC. Similarly, the
University of Chicago and the University
of California-San Diego allocate time and
financial resources for their senior residents
to pursue rotations abroad.
At present, 84 LMICs have radiation
therapy facilities. By 2020, over 12,000 radi-
ation oncologists will be needed to staff
radiation therapy facilities in these nations
(25, 26). We posit that radiation oncology
residents can play a role in addressing this
disparity, particularly in this era of expand-
ing remote telecommunication tools for
quality assurance and treatment planning
(27). Evidence suggests that short-term
rotations are beneficial for both the res-
ident and the international site provid-
ing opportunities for clinical care, knowl-
edge exchange, research collaboration, and
sustained partnerships. Through the ACR
grant, residents have engaged in projects
such as training staff to use brachytherapy
units in Botswana (28, 29) and examining
the survival rates of Ghanaian prostate can-
cer patients receiving external beam radia-
tion therapy (30). We anticipate that lon-
gitudinal follow-up of the participants in
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the aforementioned programs and detailed
reporting regarding their experiences will
shed additional light on the specific bene-
fits of these rotations.
GOING BEYOND TRAINING AND A
CAREER PATH IN GLOBAL HEALTH
Interested trainees in GH provide a com-
passionate and forward thinking poten-
tial work force to address the disparity
in oncology resources in LMICs. Yet, a
well-defined career path is needed. Senior
mentors and leaders worldwide are com-
ing together to pilot a novel solution to
GH in oncology. Signaling a transforma-
tional change that addresses both the global
need for cancer care and the desire to cre-
ate a sustainable altruistic component to
physicians’ careers, the International Can-
cer Expert Corps (ICEC), recently estab-
lished as an NGO, aims to reduce mortality
and improve the quality of life for can-
cer patients in LMICs through structured
support for dedicated faculty attempting
to establish a formal career path, with
metrics, for human service (31). This
model will also cultivate faculty who will
support residents pursuing their inter-
national health interests after training is
completed.
CONCLUSION
In recent years, a number of training pro-
grams have allowed oncology residents and
fellows to participate in international elec-
tives and to enrich their GH perspective.
These experiences have provided trainees
exposure to clinical presentations of can-
cer and approaches to cancer treatment
in diverse settings with varying availability
of resources. However, a more systematic
approach to mentorship in and learning
about GH is needed, as well as a sustainable
career path to effect change.
A proposed framework for a GH fel-
lowship includes advanced course work
such as a Masters of Public Health or
degree in tropical medicine; domestic clin-
ical medicine to maintain competencies
and potential revenue creation; academic
research; and international field work (32).
Specifically for oncology, the curriculum
should include (1) global risk factors and
epidemiological trends across geographic
regions and within tumor sites; (2) barriers
to access to radiotherapy, chemotherapy,
and surgery and innovative modalities that
can be employed in different regions; (3)
international clinical experience, with pre-
departure training and post-visit debrief-
ing; and (4) research training and experi-
ence in GH, supervised by local or inter-
national designated mentors with rele-
vant expertise. These efforts can not only
be directed toward education for both
U.S. trainees and in-country profession-
als but also must be directed at imple-
mentation and implementation research.
Training is a means to an end-provision
of high-quality and affordable cancer care,
and implementation of this care, is much
more challenging than merely training. GH
could be a specific module in all oncol-
ogy training and possibly be integrated
longitudinally within residency and fel-
lowship programs. Such approaches would
help to ensure that the GH perspective
becomes a core competency of all gradu-
ating residents.
Global health training would bene-
fit from a GH curriculum and a mech-
anism to connect trainees and faculty
engaged in this field. GlobalRT is one such
website (www.globalrt.org) that establishes
an online global radiotherapy community
(33). This site provides information about
radiotherapy within the global context,
ongoing projects, training experiences, and
research within this area. The GlobalRT
blog allows trainees and practitioners to
post accounts of their experiences in any
dimension of GH, allowing dialog and the
exchange of information about opportu-
nities in education, research, and clinical
practice.
These initiatives are invaluable
resources for oncology residents with an
interest in GH. Their successes can inform
the creation of a framework for training
oncology residents to tackle GH issues. Fur-
thermore, there is a need for the “clinical
oncologist” skilled in multimodality can-
cer care who works closely with economists
and experts in public health and policy to
address the multi-factorial issues (34).
In conclusion, the global burden of
cancer in LMICs is rising and it is
imperative that the global oncology com-
munity contributes to a solution. Med-
icine is, by definition, a humanitarian
endeavor, and bringing cancer care to
those who have had no access should
have an important place for all physicians
including those practicing in resource-rich
environments. There is increasing inter-
est in global oncology among trainees.
Although the opportunities are currently
limited, trainees are demanding more
exposure and to find ways to contribute
to solving this global epidemic. We hope
that increased focus on GH training in
the future will better prepare trainees as
global oncologists. To effectively address
the global need and the rising trainee inter-
est, fundamental changes to career paths
are required, which would provide global
benefit and serve as a model to address
other non-communicable diseases.
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